Cargando…
Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measure...
Autores principales: | Hattori, Yasushi, Tashiro, Hiromi, Kawamoto, Toshihiro, Kodama, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920667/ https://www.ncbi.nlm.nih.gov/pubmed/8636012 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x |
Ejemplares similares
-
Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020) -
Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer
por: Miki, Kazumasa, et al.
Publicado: (1993) -
Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17
levels for population-based screening for early-stage gastric
cancer
por: Wang, Yaping, et al.
Publicado: (2020) -
The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
por: Shen, Hongzhang, et al.
Publicado: (2021) -
Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)